We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » KING'S REQUEST FOR INJUNCTION IN LEVOTHYROXINE SUIT DENIED
KING'S REQUEST FOR INJUNCTION IN LEVOTHYROXINE SUIT DENIED
July 8, 2004
A federal court in the District of Columbia has refused King Pharmaceuticals’ request to revoke FDA approval of supplemental new drug applications (sNDAs) that propose to establish bioequivalence between King’s thyroid product Levoxyl and two other products: Jerome Stevens’ Unithroid and Mova Pharmaceutical’s Levo-T.